Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro is a once-weekly injection, so it is natural to think about its cost in weekly terms. Each four-week pen delivers four doses, meaning the price you pay maps directly onto roughly four weeks of treatment. As a prescription-only medicine, Mounjaro requires a clinical assessment before it can be dispensed — no pharmacy can supply it without a valid prescription reviewed by a registered prescriber. This page walks through what that weekly structure means in practice, what the evidence says about how treatment unfolds week by week, and how the cost picture becomes clearer when you understand what is actually included.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The SURMOUNT-1 study, published in the New England Journal of Medicine, followed adults with obesity over 72 weeks. Weight reduction at the highest dose averaged around 20–21% of starting body weight, but that outcome accumulated gradually, the first several weeks are largely about settling into the medicine rather than watching the scales shift dramatically.
The 2.5 mg starting dose exists specifically to reduce nausea and other gastrointestinal effects as the body adjusts. Many people find those early weeks feel unremarkable physically; the therapeutic work begins in earnest as doses increase under prescriber guidance. Thinking in weekly increments helps here: each injection is part of a longer arc, not a standalone event.
NICE's appraisal of tirzepatide, published as TA1026, noted that clinically meaningful weight loss builds over months of continued treatment alongside a reduced-calorie diet and increased activity. That framing matters when you are weighing up a weekly cost: the value compounds across weeks, not within any single one.
Because each KwikPen contains exactly four weekly doses, the arithmetic is straightforward. You inject once a week, the pen lasts four weeks, and you repeat. There is no complex scheduling, no counting individual ampoules, and if you want a fuller explanation of how that rhythm works in practice, our page on tirzepatide twice weekly dosing covers the dosing structure in detail. Most people settle into a routine quickly, the pen sits in the fridge door between uses, and injection day becomes as unremarkable as any other weekly habit.
When pharmacies or clinics quote a monthly price, they are quoting one pen. When you convert that to a weekly figure, you are simply dividing by four. The number that results only makes sense, though, if you know what it includes. A legitimate supply of Mounjaro requires a prescriber's assessment, a valid prescription, dispensing through a GPhC-registered pharmacy, and ongoing clinical oversight. At nume (at nume) one transparent price covers the consultation, prescription, treatment, and free next-working-day delivery. There are no separate line items for aftercare or repeat reviews.
For broader context on how private treatment costs compare across providers, the Mounjaro prices page sets out what the market looks like and what questions to ask before committing to any service.
Across the private market, pricing structures vary considerably. Some providers quote a figure for the pen alone, then add consultation fees, prescription fees, and delivery charges separately. Others bundle everything. The difference can be significant when you multiply it across months of treatment.
It is also worth understanding how dose titration affects cost over time. Treatment typically starts at 2.5 mg and increases in steps (5 mg, 7.5 mg, and beyond) as your prescriber judges appropriate. Higher doses may carry different prices depending on the provider. Understanding whether your quoted weekly figure is fixed or changes with each dose increase is a practical question worth asking upfront.
People considering a structured approach to spreading costs may find the Mounjaro payment plan information useful, or the broader overview on payment plans for Mounjaro if you want to compare different approaches. Some providers also offer Klarna as a payment option for those who prefer to spread the upfront cost. At nume, there are no subscriptions and no auto-renewals; every repeat order goes through a fresh clinical review before anything is dispatched.
Mounjaro is a Black Triangle medicine, meaning the MHRA requires additional monitoring while post-marketing safety data continues to build. That is not a cause for alarm (it reflects standard regulatory practice for newer medicines) but it does mean that ongoing prescriber involvement is not optional. It is built into how the medicine is properly used.
At nume, a GPhC-registered Independent Prescriber reads every consultation personally. That review happens on the same day for orders placed before 12pm Monday to Friday. It is not automated. For patients already established on treatment, weekly progress and how weight is moving inform whether dose changes are appropriate at the next review.
If you have questions about how the consultation process works or what our clinical team looks at, you can read more about our approach via the clinical team profile, or browse the FAQs for common queries. When you are ready to take the next step, speaking to our prescribers is the place to start, the consultation is free and there is no obligation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.